102 related articles for article (PubMed ID: 26482194)
1. Constitutional de novo deletion of the FBXW7 gene in a patient with focal segmental glomerulosclerosis and multiple primitive tumors.
Roversi G; Picinelli C; Bestetti I; Crippa M; Perotti D; Ciceri S; Saccheri F; Collini P; Poliani PL; Catania S; Peissel B; Pagni F; Russo S; Peterlongo P; Manoukian S; Finelli P
Sci Rep; 2015 Oct; 5():15454. PubMed ID: 26482194
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor gene FBXW7 is disrupted by a constitutional t(3;4)(q21;q31) in a patient with renal cell cancer.
Kuiper RP; Vreede L; Venkatachalam R; Ricketts C; Kamping E; Verwiel E; Govaerts L; Debiec-Rychter M; Lerut E; van Erp F; Hoogerbrugge N; van Kempen L; Schoenmakers EF; Bonne A; Maher ER; Geurts van Kessel A
Cancer Genet Cytogenet; 2009 Dec; 195(2):105-11. PubMed ID: 19963109
[TBL] [Abstract][Full Text] [Related]
3. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
[TBL] [Abstract][Full Text] [Related]
4. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
[TBL] [Abstract][Full Text] [Related]
5. FBXW7 and DNA copy number instability.
Byrd KN; Huey B; Roydasgupta R; Fridlyand J; Snijders AM; Albertson DG
Breast Cancer Res Treat; 2008 May; 109(1):47-54. PubMed ID: 17588203
[TBL] [Abstract][Full Text] [Related]
6. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
[TBL] [Abstract][Full Text] [Related]
7. Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.
Van Vlierberghe P; Homminga I; Zuurbier L; Gladdines-Buijs J; van Wering ER; Horstmann M; Beverloo HB; Pieters R; Meijerink JP
Leukemia; 2008 Apr; 22(4):762-70. PubMed ID: 18185524
[TBL] [Abstract][Full Text] [Related]
8. FBXW7 mutation analysis and its correlation with clinicopathological features and prognosis in colorectal cancer patients.
Chang CC; Lin HH; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Jiang JK; Chang SC
Int J Biol Markers; 2015 Feb; 30(1):e88-95. PubMed ID: 25450649
[TBL] [Abstract][Full Text] [Related]
9. The methylation status of FBXW7 beta-form correlates with histological subtype in human thymoma.
Gu Z; Mitsui H; Inomata K; Honda M; Endo C; Sakurada A; Sato M; Okada Y; Kondo T; Horii A
Biochem Biophys Res Commun; 2008 Dec; 377(2):685-688. PubMed ID: 18938137
[TBL] [Abstract][Full Text] [Related]
10. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
11. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW
Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478
[TBL] [Abstract][Full Text] [Related]
12. The Fbxw7/hCdc4 tumor suppressor in human cancer.
Tan Y; Sangfelt O; Spruck C
Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
[TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis in patients with complete deletion of one WT1 allele.
Iijima K; Someya T; Ito S; Nozu K; Nakanishi K; Matsuoka K; Ohashi H; Nagata M; Kamei K; Sasaki S
Pediatrics; 2012 Jun; 129(6):e1621-5. PubMed ID: 22585769
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype associations in WT1 glomerulopathy.
Lipska BS; Ranchin B; Iatropoulos P; Gellermann J; Melk A; Ozaltin F; Caridi G; Seeman T; Tory K; Jankauskiene A; Zurowska A; Szczepanska M; Wasilewska A; Harambat J; Trautmann A; Peco-Antic A; Borzecka H; Moczulska A; Saeed B; Bogdanovic R; Kalyoncu M; Simkova E; Erdogan O; Vrljicak K; Teixeira A; Azocar M; Schaefer F;
Kidney Int; 2014 May; 85(5):1169-78. PubMed ID: 24402088
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
[TBL] [Abstract][Full Text] [Related]
16. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
Park MJ; Taki T; Oda M; Watanabe T; Yumura-Yagi K; Kobayashi R; Suzuki N; Hara J; Horibe K; Hayashi Y
Br J Haematol; 2009 Apr; 145(2):198-206. PubMed ID: 19245433
[TBL] [Abstract][Full Text] [Related]
17. BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer.
Sabatier R; Adélaïde J; Finetti P; Ferrari A; Huiart L; Sobol H; Chaffanet M; Birnbaum D; Bertucci F
Genes Chromosomes Cancer; 2010 Dec; 49(12):1143-51. PubMed ID: 20842729
[TBL] [Abstract][Full Text] [Related]
18. The FBXW7 beta-form is suppressed in human glioma cells.
Gu Z; Inomata K; Ishizawa K; Horii A
Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
[TBL] [Abstract][Full Text] [Related]
19. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
[TBL] [Abstract][Full Text] [Related]
20. TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.
Nichols KE; Heath JA; Friedman D; Biegel JA; Ganguly A; Mauch P; Diller L
J Clin Oncol; 2003 Dec; 21(24):4505-9. PubMed ID: 14673037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
